WEIS, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.194
AS - Asia 2.091
EU - Europa 1.621
AF - Africa 621
SA - Sud America 452
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 29
Totale 9.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.835
SG - Singapore 814
IT - Italia 491
CN - Cina 335
BR - Brasile 279
HK - Hong Kong 277
DE - Germania 116
FI - Finlandia 96
FR - Francia 89
PL - Polonia 84
SE - Svezia 77
GB - Regno Unito 63
NL - Olanda 60
VN - Vietnam 58
RU - Federazione Russa 53
IN - India 43
BJ - Benin 42
AT - Austria 36
CA - Canada 35
MX - Messico 34
AR - Argentina 33
CH - Svizzera 33
EG - Egitto 28
KR - Corea 28
TR - Turchia 26
CZ - Repubblica Ceca 25
IQ - Iraq 25
DO - Repubblica Dominicana 24
IE - Irlanda 24
MZ - Mozambico 24
UA - Ucraina 24
AE - Emirati Arabi Uniti 23
AO - Angola 22
ES - Italia 22
IR - Iran 22
JP - Giappone 22
BA - Bosnia-Erzegovina 21
DZ - Algeria 21
MN - Mongolia 21
CR - Costa Rica 20
HN - Honduras 20
RO - Romania 20
SI - Slovenia 20
SK - Slovacchia (Repubblica Slovacca) 20
SN - Senegal 20
AM - Armenia 19
BY - Bielorussia 19
CI - Costa d'Avorio 19
CL - Cile 19
CO - Colombia 19
GT - Guatemala 19
JO - Giordania 19
LA - Repubblica Popolare Democratica del Laos 19
PR - Porto Rico 19
TH - Thailandia 19
TJ - Tagikistan 19
YT - Mayotte 19
ZA - Sudafrica 19
EC - Ecuador 18
EE - Estonia 18
KE - Kenya 18
LB - Libano 18
ML - Mali 18
NI - Nicaragua 18
PA - Panama 18
UG - Uganda 18
VE - Venezuela 18
BF - Burkina Faso 17
CU - Cuba 17
GM - Gambi 17
KG - Kirghizistan 17
KZ - Kazakistan 17
NO - Norvegia 17
RS - Serbia 17
SA - Arabia Saudita 17
BB - Barbados 16
LC - Santa Lucia 16
NZ - Nuova Zelanda 16
PH - Filippine 16
PK - Pakistan 16
TN - Tunisia 16
TT - Trinidad e Tobago 16
TZ - Tanzania 16
XK - ???statistics.table.value.countryCode.XK??? 16
AD - Andorra 15
AF - Afghanistan, Repubblica islamica di 15
BS - Bahamas 15
BW - Botswana 15
ET - Etiopia 15
GN - Guinea 15
ID - Indonesia 15
IL - Israele 15
KH - Cambogia 15
LV - Lettonia 15
LY - Libia 15
MD - Moldavia 15
PS - Palestinian Territory 15
UY - Uruguay 15
UZ - Uzbekistan 15
AL - Albania 14
Totale 8.433
Salva come PNG Salva come JPEG
Città #
Fairfield 547
Singapore 503
Ashburn 477
Hong Kong 269
Woodbridge 247
Houston 218
Seattle 218
Chandler 206
Cambridge 197
Santa Clara 171
Ann Arbor 163
Wilmington 148
Beijing 127
Boardman 105
Padova 68
Bytom 62
Milan 62
San Diego 62
Los Angeles 58
Princeton 50
Medford 48
Rome 46
Munich 45
Cotonou 41
Helsinki 37
Des Moines 36
Chicago 34
Lyon 32
Hefei 31
Roxbury 29
Turku 29
New York 27
São Paulo 27
Buffalo 25
Vienna 21
Cairo 20
Maputo 20
Ulan Bator 20
Dakar 19
Ho Chi Minh City 19
Luanda 19
Abidjan 18
Bamako 18
Dublin 18
Kampala 18
Amman 17
Dushanbe 17
Panama City 17
Bishkek 16
London 16
Managua 16
Yerevan 16
Andorra la Vella 15
Bridgetown 15
Castries 15
Conakry 15
Guangzhou 15
Havana 15
Vientiane 15
Lusaka 14
Montevideo 14
Nairobi 14
Nassau 14
San José 14
Seoul 14
Stockholm 14
Tashkent 14
Dar es Salaam 13
Kigali 13
Minsk 13
Montreal 13
Noumea 13
Ouagadougou 13
Phnom Penh 13
Prague 13
Tallinn 13
Belgrade 12
Libreville 12
Nanjing 12
Pristina 12
Pune 12
Accra 11
Bangkok 11
Banjul 11
Gaborone 11
Oslo 11
Riga 11
Salt Lake City 11
San Pedro Sula 11
Santo Domingo 11
Tbilisi 11
Addis Ababa 10
Antananarivo 10
Dili 10
Frankfurt am Main 10
Guatemala City 10
Hanoi 10
Ljubljana 10
Naples 10
Niamey 10
Totale 5.364
Salva come PNG Salva come JPEG
Nome #
Brain anatomical substrates of mirror movements in Kallmann syndrome 264
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale 213
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 180
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 166
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown 163
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 159
The role of limbic structures in financial abilities of mild cognitive impairment patients 158
Cortical gamma-synchrony measured with magnetoencephalography is a marker of clinical status and predicts clinical outcome in stroke survivors. 157
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 156
Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study 156
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 155
Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model 153
Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients 150
Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia 147
Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives 146
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 143
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 142
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 141
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 140
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 137
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 135
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts 134
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 134
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 133
Grey matter changes in cognitively impaired Parkinson's disease patients 132
Improving the reliability of single-subject fMRI by weighting intra-run variability 127
Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson’s disease patients 127
Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies 126
Anatomical profile of cognitive impairment in MSA 125
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 124
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion 123
Effects of Functional Electrical Stimulation Lower Extremity Training in Myotonic Dystrophy Type I: A Pilot Controlled Study 123
Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort 122
Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report 122
Efficacy of a Training on Executive Functions in Potentiating Rehabilitation Effects in Stroke Patients 122
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease 121
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 121
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 121
Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report 120
A retrospective cohort study of young women spontaneously choosing to be vaccinated against hpv: Outcomes from their first cervical cancer screening test 119
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 117
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy 116
tDCS effect on cognitive performance in Parkinson's disease 114
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study 114
Anatomical and functional correlates of persistent pain in Parkinson's disease 113
Anatomical and functional correlates of persistent pain in Parkinson's disease 112
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 110
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 107
Deep brain stimulation in Parkinson's disease: A multicentric, long-term, observational pilot study 107
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 105
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 104
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson’s disease: a multicenter, retrospective study of efficacy and safety 103
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7) 103
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 102
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia 101
Neurocognitive correlates of numerical abilities in Parkinson’s disease 99
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson’s disease: a multicenter, retrospective study of efficacy and safety 97
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 94
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 94
Awake surgery and cortico-subcortical mapping: Neurosurgery of Udine esperience based on consecutive 316 cases 86
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 79
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 77
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 76
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 76
Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus 72
Alpha‐synuclein RT‐QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 72
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy 71
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 71
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 68
Rule-based or fact retrieval: one and zero multiplications are not equally processed 68
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 66
Bilateral Transcranial Direct Current Stimulation Reshapes Resting-State Brain Networks: A Magnetoencephalography Assessment 64
Abnormal Gyrification in Brain of early onset Myotonic Dystrophy patients 61
Cognitive decline in Parkinson's disease: the complex picture 59
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 57
Surgery of insular nonenhancing gliomas: Volumetric analysis of tumoral resection, clinical outcome, and survival in a consecutive series of 66 cases 55
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 54
Transcranial direct current stimulation over the sensory-motor regions inhibits gamma synchrony 52
Grey matter changes in cognitively impaired Parkinson's disease patients 51
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 43
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 41
null 40
Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort 18
Totale 9.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.559
article - articoli 30.377
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.936
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 20 75 39 36 68 42 90 51
2021/2022815 103 64 73 53 16 100 42 62 33 70 50 149
2022/2023634 78 11 24 48 115 93 4 70 109 10 59 13
2023/2024592 39 81 55 38 39 82 65 36 32 21 55 49
2024/20252.102 18 146 76 75 296 69 150 157 159 134 328 494
2025/20263.410 378 526 1.122 1.256 128 0 0 0 0 0 0 0
Totale 9.226